Evidence map›Paper›PMID 25313925›Full record

ArticlePloS one2014

Potentiated interaction between ineffective doses of budesonide and formoterol to control the inhaled cadmium-induced up-regulation of metalloproteinases and acute pulmonary inflammation in rats.

Wenhui Zhang, Jianming Zhi, Yongyao Cui, Fan Zhang, Adélite Habyarimana, Carole Cambier, Pascal Gustin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Wenhui ZhangDepartment of Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Jianming ZhiDepartment of Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Yongyao CuiDepartment of Pharmacology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Fan ZhangDepartment of Pathology, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Adélite HabyarimanaDepartment for Functional Sciences B41, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium.
Carole CambierDepartment for Functional Sciences B41, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium.
Pascal GustinDepartment for Functional Sciences B41, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium.
Shanghai Jiao Tong University · CNUniversity of Liège · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The anti-inflammatory properties of glucocorticoids are well known but their protective effects exerted with a low potency against heavy metals-induced pulmonary inflammation remain unclear. In this study, a model of acute pulmonary inflammation induced by a single inhalation of cadmium in male Sprague-Dawley rats was used to investigate whether formoterol can improve the anti-inflammatory effects of budesonide. The cadmium-related inflammatory responses, including matrix metalloproteinase-9 (MMP-9) activity, were evaluated. Compared to the values obtained in rats exposed to cadmium, pretreatment of inhaled budesonide (0.5 mg/15 ml) elicited a significant decrease in total cell and neutrophil counts in bronchoalveolar lavage fluid (BALF) associated with a significant reduction of MMP-9 activity which was highly correlated with the number of inflammatory cells in BALF. Additionally, cadmium-induced lung injuries characterized by inflammatory cell infiltration within alveoli and the interstitium were attenuated by the pre-treatment of budesonide. Though the low concentration of budesonide (0.25 mg/15 ml) exerted a very limited inhibitory effects in the present rat model, its combination with an inefficient concentration of formoterol (0.5 mg/30 ml) showed an enhanced inhibitory effect on neutrophil and total cell counts as well as on the histological lung injuries associated with a potentiation of inhibition on the MMP-9 activity. In conclusion, high concentration of budesonide alone could partially protect the lungs against cadmium exposure induced-acute neutrophilic pulmonary inflammation via the inhibition of MMP-9 activity. The combination with formoterol could enhance the protective effects of both drugs, suggesting a new therapeutic strategy for the treatment of heavy metals-induced lung diseases.

Indexed as

Acute DiseaseAdministration, InhalationAnimalsAnti-Inflammatory AgentsBronchoalveolar Lavage FluidBudesonideCadmiumChemokinesCytokinesEthanolaminesFormoterol FumarateLeukocyte CountLungMaleMatrix Metalloproteinase 9NeutrophilsAnti-Inflammatory AgentsBudesonideCadmiumChemokinesCytokinesEthanolaminesFormoterol FumarateMatrix Metalloproteinase 9

Identifiers

PMID25313925
PMCPMC4196767
OpenAlexW1969691544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.